Weight Loss / Peptide Protocols

Peptide Weight Loss in San Diego, CA — GHRH & Body Composition Protocols

Peptide weight loss in San Diego — sermorelin, CJC/ipamorelin, and tesamorelin protocols for body composition and visceral fat reduction. By Dr. Joseph Dubroff, N.D.

Peptide weight loss GHRH San Diego body composition
Body Composition vs. Scale Weight

When the Number on the Scale Isn't the Whole Story.

Not every weight-loss patient is trying to lose 50 pounds. Some patients are at a reasonable weight but the composition of that weight is wrong — too much fat (particularly visceral abdominal fat), not enough muscle, and a body that doesn't look or function the way it should despite reasonable diet and training. For these patients, the question isn't "how do I lose 50 pounds" — it's "how do I shift the ratio of what I'm carrying."

Peptide-based weight loss works on this problem differently than GLP-1 or HCG. Rather than driving overall caloric restriction and general weight loss, peptide protocols work through the growth hormone axis and related signaling systems to specifically affect body composition — preserving lean muscle, mobilizing fat (particularly visceral fat), supporting metabolic function, and improving recovery so training produces better results.

This is the path for patients whose primary issue isn't general overweight — it's stubborn abdominal fat, poor body composition, metabolic shifts of perimenopause or andropause, or the gradual body composition decline of aging. It pairs well with the broader Holistic Solutions toolkit (hormone optimization, dietary support, training guidance) and produces a different kind of result than GLP-1.

The Peptide Toolkit

Three Peptide Categories. Different Roles in Body Composition.

Each of these peptides works on the GH/IGF-1 axis or related pathways to affect body composition. The specific protocol depends on what your case calls for.

Peptide vs. GLP-1 Approach

Different Tools, Different Outcomes.

Patients often ask whether they should pursue peptides or GLP-1. The honest answer is that they do different things — and for some patients, the combination is the right answer. Here's how the approaches compare.

GLP-1 Medications

Drive Scale Weight Loss

Work by reducing appetite and slowing gastric emptying, producing caloric deficit and overall weight loss across both visceral and subcutaneous fat. Strong total-weight reduction. Less specific to body composition. Best for patients with significant weight to lose where the scale number is the primary metric.

Peptide Protocols

Shift Body Composition

Work through the GH/IGF-1 axis to mobilize fat (particularly visceral), preserve lean mass, and improve recovery. Less impact on overall scale weight; more impact on fat-to-muscle ratio and body composition. Best for patients whose primary issue is composition rather than absolute weight, or for patients pairing with lifestyle changes.

Common Questions

Peptide Weight Loss FAQs

How much weight will I actually lose on peptides?+
Peptide-based body composition is generally not the right tool for major scale-weight loss. Typical results focus more on composition than absolute weight — patients often report measurable waist measurement changes, leaner overall appearance, better muscle definition, and visceral fat reduction without dramatic scale shifts. If your primary metric is scale weight and you have 30+ pounds to lose, GLP-1 will likely be the better tool. If your primary concern is body composition or stubborn abdominal fat, peptides may be the right path.
Can I combine peptides with GLP-1?+
Yes — and combined protocols can produce results neither approach achieves alone. A common combination: GLP-1 for the active rapid-weight-loss phase, then transitioning to peptide protocols for body composition refinement and lean mass preservation during maintenance. Tesamorelin specifically pairs well with GLP-1 because it targets the visceral fat depot directly while GLP-1 produces broader caloric deficit. Dr. Dubroff designs combinations based on what your case calls for.
How long do peptide protocols run?+
Typically 3-6 months for an active cycle, with reassessment based on response. Some patients run periodic cycles with breaks in between. Some maintain longer-term protocols with periodic monitoring. Tesamorelin specifically is typically run for 6 months at a time for visceral fat reduction. Dr. Dubroff designs the timeline based on your goals and clinical picture.
Are these peptides FDA-approved?+
Mixed regulatory status. Tesamorelin is FDA-approved as Egrifta for HIV-related lipodystrophy — used off-label for other visceral fat applications. Sermorelin was originally FDA-approved (as Geref) for pediatric growth hormone deficiency; the branded product was discontinued in 2008 and it's now compounded for adult use. CJC-1295 and ipamorelin are not FDA-approved and are used off-label via licensed compounding pharmacies. Dr. Dubroff discusses regulatory status openly during the consultation.
What about side effects?+
GHRH and GH-axis peptides generally have favorable side-effect profiles. Common: mild injection-site reactions, occasional vivid dreams (a side effect of deeper sleep), transient headaches early in protocol. Less common: temporary glucose changes, fluid retention. Because these peptides work through the body's natural feedback systems rather than introducing direct hormone replacement, the side effects associated with synthetic growth hormone are far less common. Tesamorelin specifically requires glucose monitoring and is used cautiously in diabetic patients.
How are these peptides administered?+
All via subcutaneous injection using a small insulin-style needle. Most are administered once daily — sermorelin and CJC/ipamorelin typically before bed to align with the body's natural GH pulse during deep sleep; tesamorelin once daily, typically into the abdomen. Patients self-administer at home after a brief walkthrough. The injection takes seconds and is essentially painless.
Will my IGF-1 need to be monitored?+
Yes for any GH-axis protocol. IGF-1 (insulin-like growth factor 1) is the primary marker for GH activity in the body. Dr. Dubroff orders baseline IGF-1 before starting any GHRH protocol and retests at the 8-12 week mark to confirm response and verify levels are in a healthy range. Tesamorelin also requires periodic glucose monitoring. Dose adjustments are made based on these labs.
Medical Disclaimer: Information on this page is for educational purposes and does not constitute medical advice. Sermorelin, CJC-1295, and ipamorelin are used off-label for adult body composition support under physician supervision via licensed compounding pharmacies. Tesamorelin is FDA-approved for HIV-related lipodystrophy and is used off-label for other visceral fat applications. Tesamorelin can affect glucose regulation and is used cautiously in diabetic patients. Individual results vary, and not every patient is a candidate. Always discuss benefits and risks with a qualified healthcare provider before starting any peptide therapy.
Get Started

Composition Over Just Scale Weight.

Book a free consultation. Dr. Dubroff will tell you whether peptide-based body composition is the right path — or whether GLP-1, HCG, or a combination would serve you better.